Argint International Clinical Research and Development Services (Argint)
Argint International Clinical Research and Development Services (Argint) is recognized as a leading regional CRO, providing clinical research services throughout Europe, but with a primary focus on Central and South Eastern Europe (CEE). Argint is focused on providing tailor made full-service solutions to small and medium sized biotech companies, partnering clients as they bring their drug candidates or devices into the clinical phase. Argint supports the planning and execution of our clientâ€™s development programs: from initial consultancy through phase I, POC and larger phase II and phase III studies. We provide a â€˜one-stop shopâ€™ for all clinical outsourcing needs in Europe. In September 2018, Argint joined Precision for Medicine, part of Precision Medicine Group, with more than 1,450 employees in 25 locations in the US, Canada, and Europe. Precisionâ€™s integrated set of capabilities across global clinical trial execution, sophisticated biomarker and specialty lab solutions will now be available to Argintâ€™s clients to help address the many unique and complex challenges of bringing an innovative drug to market. In addition, by leveraging Precisionâ€™s extensive North American clinical trials footprint, Argint clients will now be able to conduct clinical trials in regions not previously available. Together, Precision and Argint create a unique, fully-integrated solution to support the critical needs of emerging clients throughout Europe and North America in the rapidly-growing precision medicine space.
Offices in Hungary:
BÃ¶lÃ¶ni GyÃ¶rgy u. 22,1021, Budapest